Since going public, medical imaging start-up Nanox has seen the price of its shares tumultuously rise and fall as various pieces of information and allegations have come to light. This insight asks whether Nanox really is about to revolutionise medical imaging, or whether perhaps expectations need to be revised.
Read the full insight with a Signify Premium Insights - Medical Imaging subscription